What we do
Corporate Governance Advisory Services
ESG Advisory Services
Proxy Solicitation and Shareholder Meeting Services
Capital Market Intelligence Services
M&A and Information Agent Services
Proxy Contests, Hostile takeovers, Shareholder Activism and Special Situations
Retail Services and Additional Capabilities
Debt Services
Board of Director Services
Services for Registered Funds - Mutual Funds, Exchange Traded Funds (ETFs) and Closed-End Funds - Di Costa Partners
Client Portal

Recent Deals

Celgene Acquisition by Bristol-Myers Squibb

Celgene Corporation (NASDAQ: CELG) and Bristol-Myers Squibb Company (NYSE: BMY), a Delaware corporation, agreed to a Plan of Merger, dated as of January 2, 2019.

Morrow Sodali served as proxy solicitor for this transaction.

Find more information here

Topics

Celgene Acquisition by Bristol-Myers Squibb

Topics

Celgene Corporation (NASDAQ: CELG) and Bristol-Myers Squibb Company (NYSE: BMY), a Delaware corporation, agreed to a Plan of Merger, dated as of January 2, 2019.

Morrow Sodali served as proxy solicitor for this transaction.

Find more information here

© 2016 - 2020 Morrow Sodali